发明授权
US07834060B2 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
有权
施用6- [3-（1-金刚烷基）-4-甲氧基苯基] -2-萘甲酸用于治疗皮肤病
![Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders](/docs/US/2010-11-16/US07834060B2/abs.jpg.600x600.jpg)
- 专利标题： Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
- 专利标题（中）： 施用6- [3-（1-金刚烷基）-4-甲氧基苯基] -2-萘甲酸用于治疗皮肤病
-
申请号： US12437008申请日： 2009-05-07
-
公开(公告)号： US07834060B2公开(公告)日： 2010-11-16
- 发明人: Michael Graeber , Janusz Czernielewski
- 申请人： Michael Graeber , Janusz Czernielewski
- 申请人地址： FR Biot
- 专利权人： Galderma Research & Development
- 当前专利权人： Galderma Research & Development
- 当前专利权人地址： FR Biot
- 代理机构： Buchanan Ingersoll & Rooney PC
- 优先权： FR0203070 20020312
- 主分类号： A01N37/10
- IPC分类号： A01N37/10 ; A01N37/00 ; A61K31/19 ; A61K31/185 ; A61K8/02
![Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders](/abs-image/US/2010/11/16/US07834060B2/abs.jpg.150x150.jpg)
摘要：
Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
公开/授权文献
信息查询
